The Licensing Revenue Your Balance Sheet Is Ignoring

A balance sheet that protects what it never puts to work isn't strategy — it's storage.

I have spent three decades sitting with executive teams who can recite their capital structure in detail, yet struggle to articulate the full earning potential of what they already own. Not their plants. Not their people. Their ideas.

Intellectual property often sits quietly on the balance sheet, treated as something to protect rather than something to produce. That posture leaves value dormant — and in many mid-market companies, that dormant value is material.

A persistent pattern in manufacturing and industrial sectors involves near-total focus on the physical unit — the precision-engineered component, the proprietary compound — as the sole driver of revenue. Growth stays tethered to factory throughput. What rarely enters the conversation is the IP embedded in how those products are made or differentiated.

Licensing changes the posture entirely. It converts intellectual property into a revenue stream that scales without adding operating strain. No new factories. No expanded headcount. No incremental working capital.

Charles Handy, the Irish management philosopher, wrote in The Elephant and the Flea: "Forget land, buildings, or machines — the real source of wealth today is intelligence, applied intelligence. We talk glibly of 'intellectual property' without taking on board what it really means. It isn't just patent rights and brand names; it is the brains of the place."

Handy wrote that more than two decades ago. Most organizations still haven't fully reckoned with it.

Licensing Revenue as an Active Strategy

Licensing is not a defensive move and not a secondary option when core growth slows. It is a parallel path to revenue operating under a fundamentally different set of constraints — scaling through partners, not payroll, converting knowledge into cash flow with minimal marginal cost.

The global IP licensing market reached approximately $340 billion in 2024, according to DataHorizzon Research, with projections exceeding $580 billion by 2033. The World Intellectual Property Organization (WIPO)'s Global Innovation Index trade data shows cross-border IP payments have already surpassed $1 trillion, growing at a compound annual rate of 5.5%. That is an asset class — and most mid-market companies are sitting on the wrong side of it.

The companies generating licensing revenue are not all technology giants. They include manufacturers with proprietary process improvements, professional services firms with branded methodologies, consumer companies with trademark equity in adjacent categories, and regional players whose operational know-how has genuine value in markets where they don't compete.

What makes licensing different from every other growth strategy is its cost profile. New headcount adds payroll. New markets require capital. New products require development capacity. A licensing program, once structured, generates revenue that does not scale with your cost base. The IP is already built.

The question is not whether your company has licensable IP. The question is whether anyone has ever seriously looked.

What the Audit Actually Surfaces

Most executives assume they understand their IP portfolio. In practice, they understand what they filed — not what they can monetize.

Kevin Rivette and David Kline, in Rembrandts in the Attic: Unlocking the Hidden Value of Patents (2000), documented what most corporate IP programs actually are: corporations paying ongoing maintenance fees — a recurring property tax — on portfolios where 70% to 80% of patents sit entirely idle. Never licensed, never deployed, never leveraged. Just maintained as a legal expense.

That is not IP strategy. That is IP housekeeping.

A licensing-focused audit starts from a different premise. Every asset the company has developed — every process, every system, every branded framework, every piece of proprietary data — should be evaluated for external value, not just internal utility.

Four questions apply to each asset:

• Does it solve a problem that other companies face?

• Could another company use it without competing directly with you?

• Is it defensible — clear ownership, some form of documented protection?

• Would the cost of licensing it out be materially lower than the revenue it could generate?

In practice, the audit surfaces three categories worth examining:

Process innovations are often the most immediately valuable and the most overlooked. When an organization has developed a faster, safer, or more cost-effective way to produce something, other firms will pay to adopt that advantage without the trial and error. This category tends to be underleveraged because it feels operational rather than strategic. What the team treats as a workaround — a hardware modification, a production script, a scheduling method that cuts cycle time — can be highly differentiated to someone outside your industry.

Proprietary technology and data assets remain the dominant category. PatentPC reported in 2024 that over 40% of technology companies engaged in patent licensing that year, with pharmaceutical companies accounting for 25% of all patent licensing revenues. Software patents account for roughly 22% of all licensed patents globally — a category that increasingly includes proprietary platforms, logistics algorithms, and analytics frameworks built for internal use that turn out to have broader application.

Branded methodologies and frameworks are the most underestimated category in the mid-market. If your firm has developed a service approach, a training curriculum, a quality management system, or a proprietary diagnostic tool that consistently produces results, that is IP. Consulting firms license their frameworks to training organizations. Manufacturers license process methodologies to their suppliers. The value is real — it just requires intentional packaging and a deliberate decision to treat the methodology as a product.

Kepner-Tregoe is a precise proof of concept. Founded in 1958 by Dr. Charles Kepner and Dr. Benjamin Tregoe, the firm developed a proprietary rational methodology for problem analysis, decision analysis, and situation appraisal — built originally as a structured alternative to the intuition-driven approaches that dominated management practice at the time. Rather than deploying it exclusively through consulting engagements, Kepner-Tregoe built a licensing model around it. They certify internal employees within client organizations — corporations and government bodies worldwide — to teach and apply the KT methodology independently. That train-the-trainer architecture is the engine. It allows the methodology to scale across millions of users without a proportional increase in Kepner-Tregoe's own headcount, generating continuous revenue through organizational licenses, certification programs, and training material royalties. The methodology earns. The firm doesn't have to grow to capture that earning.

The European Union Intellectual Property Office (EUIPO) and the European Patent Office (EPO) joint research on IP rights and firm performance found that companies holding IP generate 20% to 23.8% higher revenue per employee than firms without — with the premium reaching up to 44% for mid-market enterprises. The firms that monetize their IP don't just protect value. They compound it.

The Hesitation Worth Addressing

The primary barrier to licensing revenue is rarely a lack of intellectual property. It is a fear of giving away the secret sauce.

Executive teams frequently argue that licensing technology will eventually arm competitors. That concern reflects a misreading of market boundaries. Strategic licensing targets what might be called the adjacent possible — industries that rely on similar technology but never compete for the same customers. A construction firm's soil-stabilization chemistry licensed to a residential landscaping conglomerate does not threaten its commercial pipeline. A manufacturer's proprietary coating process licensed to an aerospace supplier does not touch its core industrial customer base.

Beth Comstock, former Vice Chair of GE and author of Imagine It Forward: Courage, Creativity, and the Power of Change, identified the central challenge as a failure of letting go — the tendency of established organizations to choke an idea through territorial ownership rather than allowing it to find its best use externally. The organizations that overcome that resistance don't give their IP away. They structure access deliberately, retain full ownership, and collect revenue from industries they would never enter on their own.

Paul Romer, awarded the Nobel Prize in Economics in 2018, built his theory of endogenous growth on a single insight: unlike physical goods, an idea used by one party is not diminished for another. A design, a method, a process — once created, it can be deployed across multiple licensees without being consumed. You are not selling the asset. You are renting access to it while retaining everything that makes it valuable.

Deal Structures That Actually Get Signed

Understanding the IP is only half the challenge. Execution is where most companies stall.

Exclusive licenses grant one licensee rights within a defined scope — a geography, vertical, or application. They command higher royalties because the licensee is paying for market protection. Minimum royalty floors and performance benchmarks are not optional in these structures. They are the mechanism that prevents a slow licensee from leaving the IP earning nothing for the duration of the term.

Non-exclusive licenses allow multiple licensees simultaneously. The royalty per deal is lower, but aggregate revenue potential is higher and risk is spread. For patents and software IP, this is often the most practical structure.

Field-of-use licenses restrict the licensee to a specific application, leaving you free to license the same asset to different parties in unrelated fields. One asset, multiple revenue streams, no cannibalization.

Hybrid minimum structures pair a smaller upfront payment with ongoing royalties and a guaranteed annual floor — protecting the licensor against slow traction while preserving shared upside.

Royalty structures fall into three forms: a percentage of licensee revenue tied to use of the IP, a flat fee per unit, or a blended arrangement combining a lower royalty rate with an upfront license fee.

What kills deals — consistently — is not price. It is ambiguity. Agreements collapse when license scope is imprecise, audit rights are vague, termination conditions are unclear, or improvement rights — who owns enhancements the licensee develops during the term — are left unresolved. These are not legal fine points. They are commercial ones.

The Revenue Profile Nobody Is Forecasting

IBM built one of the most productive patent licensing programs in corporate history — generating over $1 billion annually in high-margin IP revenue for most years after 1996 and accumulating more than $27 billion in cumulative licensing income over the program's lifespan. Much of that revenue came from patents unconnected to IBM's active product strategy at the time — foundational networking, data-routing, and e-commerce innovations from the 1980s and 1990s that companies in social media, gaming, and e-commerce later needed to build modern applications. The principle that drove it: IP can generate income from businesses you will never compete in, serving customers you will never sell to, without a single additional hire.

Dolby Laboratories built its entire business model on exactly that logic. Founded on a single noise-reduction technology developed for studio recording, Dolby grew into a licensing engine — collecting per-device royalties from consumer electronics manufacturers worldwide. Today, licensing accounts for the majority of Dolby's revenue. The company makes almost nothing itself. It earns from what others make using its IP.

A process patent, a branded framework, a proprietary methodology — licensed to one or two operators in non-competing markets — generates meaningful recurring revenue from assets already being maintained.

That revenue belongs on your five-year financial plan. Most finance teams haven't modeled it. Most CEOs haven't asked for it.

Your balance sheet is holding assets that aren't earning. The audit starts with a conversation — not with legal, but with your operating leadership — about what the company knows how to do that others don't, and what competitors are already trying to replicate.

The first licensing deal is always harder than the second. After that, the program runs.

Turn IP Into a Revenue Line

Aspirations Consulting Group works with mid-market and Fortune 1000 executives to identify, structure, and commercialize licensing opportunities from IP assets currently treated as operational or protective resources. Our strategic IP monetization work maps your intellectual property against market needs and designs deal structures that protect your core while funding your future. If you've never conducted a business-focused IP audit, that conversation is often the most profitable one you'll have this year. Schedule a confidential consultation at https://www.aspirations-group.com.

Stay Ahead of the Conversation

If today's blog opened a question you haven't asked before, there are more like it waiting for you. Subscribe to ACG Strategic Insights at https://www.aspirations-group.com/subscription — published each weekday and read by more than 10 million current and aspiring executives around the world.

Thanks for reading!

~ Jerry Justice

Living to Serve, Serving to Lead™